Terns Pharmaceuticals, Inc. (TERN)
40.14
-0.26
(-0.64%)
USD |
NASDAQ |
Jan 02, 16:00
40.14
0.00 (0.00%)
After-Hours: 19:19
Terns Pharmaceuticals Research and Development Expense (TTM): 76.99M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Altimmune, Inc. | 67.72M |
| Ligand Pharmaceuticals, Inc. | 82.10M |
| ADMA Biologics, Inc. | 3.776M |
| Viking Therapeutics, Inc. | 222.48M |
| Cidara Therapeutics, Inc. | 131.82M |